Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to the letter to the editor by Hafer and Johnson concerning 'Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain'.
Ottoboni T, Quart B, Pawasauskas J, Dasta JF, Pollak RA, Viscusi ER. Ottoboni T, et al. Among authors: quart b. Reg Anesth Pain Med. 2020 Dec;45(12):1031-1032. doi: 10.1136/rapm-2020-101488. Epub 2020 Jun 2. Reg Anesth Pain Med. 2020. PMID: 32487703 Free PMC article. No abstract available.
HTX-019 via 2-min injection or 30-min infusion in healthy subjects.
Ottoboni T, Lauw M, Keller MR, Cravets M, Manhard K, Clendeninn N, Quart B. Ottoboni T, et al. Among authors: quart b. Future Oncol. 2019 Mar;15(8):865-874. doi: 10.2217/fon-2018-0809. Epub 2018 Dec 21. Future Oncol. 2019. PMID: 30574797 Free article. Clinical Trial.
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia.
Fleischmann R, Kerr B, Yeh LT, Suster M, Shen Z, Polvent E, Hingorani V, Quart B, Manhard K, Miner JN, Baumgartner S; RDEA594-111 Study Group. Fleischmann R, et al. Among authors: quart b. Rheumatology (Oxford). 2014 Dec;53(12):2167-74. doi: 10.1093/rheumatology/ket487. Epub 2014 Feb 8. Rheumatology (Oxford). 2014. PMID: 24509406 Clinical Trial.
Erratum to: Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.
Miner JN, Tan PK, Hyndman D, Liu S, Iverson C, Nanavati P, Hagerty DT, Manhard K, Shen Z, Girardet JL, Yeh LT, Terkeltaub R, Quart B. Miner JN, et al. Among authors: quart b. Arthritis Res Ther. 2016 Oct 12;18(1):236. doi: 10.1186/s13075-016-1150-7. Arthritis Res Ther. 2016. PMID: 27733209 Free PMC article. No abstract available.
25 results